Tag: CardioCel®
Admedus sells its CardioCel and VascuCel patch business for $A36.2m
ASX-listed health technologies manufacturer Admedus has reached an agreement to sell its CardioCel and VascuCel patch business to US based LeMaitre Vascular Inc. for up to...
Admedus completes acquisition of WA manufacturing site for CardioCel
Admedus has announced that it has completed the purchase of an established manufacturing site from Genzyme Australia to facilitate increased production of its lead...
Featured Article
Unlocking growth: Charting midsize manufacturers’ path with digital solutions
According to a recent study by Oxford Economics, midsized companies in the industrial manufacturing sector are setting their eyes on ambitious growth targets. The research, authored in partnership with SAP, revealed that 38% of industry leaders have identified market expansion as their top priority.
